Takeaways: CDA’s draft recommendation could expand Spinraza’s reimbursed market in Canada by extending coverage to adults and patients with two, three or four SMN2 gene copies, strengtheni...
Browsing Tag: SMA type 3
Takeaways: CDA’s draft recommendation could expand Spinraza’s reimbursed market in Canada by extending coverage to adults and patients with two, three or four SMN2 gene copies, strengtheni...